Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Ping Wu, Wei Ling, Chengwei Luo Luo, Lisi Huang, Ruohao Xu, Xiaoling Liang, Jiaqi Tan, Jinghua Wang, Peilong Lai, Suijing Wu, Birong Li, Haijie Huang, Suxia Geng, Xin Du, Jianyu Weng

Blood (2024) 144 (Supplement 1): 1575.

https://doi.org/10.1182/blood-2024-210697

Published: 2024

Journal Articles

First-in-Class JAK/Rock Inhibitor Rovadicitinib in Myeloproliferative Neoplasms: A Single Arm, Multicenter, Open-Label, Phase I/Ib Study

Zefeng Xu, Ling Pan, Zhenya Hong, Qingsong Yin, Xuelan Zuo, Qin Wen, Fan Yu, Chunkang Chang, Wei Ling, Dong Wang, Dawei Ding, Zhijian Xiao

Blood (2023) 142 (Supplement 1): 1829.

https://doi.org/10.1182/blood-2023-178956

Published: 2023

Journal Articles

Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center

Ping Wu, Wei Ling, Chengwei Luo, Xiaomei Chen, Lisi Huang, Jinghua Wang, Peilong Lai, Suijing Wu, Xin Du, Jianyu Weng

Blood (2023) 142 (Supplement 1): 2890.

https://doi.org/10.1182/blood-2023-187924

Published: 2023

Journal Articles

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Cheng Zhang, MD PhD, Lei Gao, Yao Liu, Li Gao, Pei-Yan Kong, Jun Liu, Ruihao Huang, Ying-Ying Ma, Defu Zeng, MD PhD, Qing-Hui Xiong, Wei-Ling Mei, Jia Liu, Peng-Fei Jiang, Xun Ye, De-Ping Han, Wei Cao, Xi Zhang

Blood (2019) 134 (Supplement_1): 4561.

https://doi.org/10.1182/blood-2019-128262

Published: 2019

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

Stephen B Ting, MB BS, FRACP, FRCPA, PhD, Chin Hin Ng, MD MRCP, Ashish Bajel, MBBS, FRACP, FRCPA, William YK Hwang, MBBS, FRCP(London), MMed(Int MD, FAMS, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Mark McHale, B.S., PhD, Chih-Yi Hsieh, MD, Hsuan-Jen Shih, MD, Nicola McIntyre, PhD, Jamie Kwek, Wei-Ling Chang, PhD, Bertil Lindmark, MD PhD

Blood (2018) 132 (Supplement 1): 2676.

https://doi.org/10.1182/blood-2018-99-110570

Published: 2018

Journal Articles

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Blood (2016) 128 (22): 4538.

https://doi.org/10.1182/blood.V128.22.4538.4538

Published: 2016

Journal Articles

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Jianyu Weng, Xin Huang, Xiaomei Chen, Qiong Luo, Jianhua Su, Jiaqi Tong, Zhi Cao, Peilong Lai, Suijing Wu, Chengwei Luo, Wei Ling, Xin Du

Blood (2015) 126 (23): 5420.

https://doi.org/10.1182/blood.V126.23.5420.5420

Published: 2015

Journal Articles

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Jianyu Weng, MD, Xin Huang, Suxia Geng, Chengwei Luo, Suijing Wu, Wei Ling, Rong Guo, Zesheng Lu, Chengxin Deng, Pengxiang Andy, Xin Du

Blood (2012) 120 (21): 4673.

https://doi.org/10.1182/blood.V120.21.4673.4673

Published: 2012

Journal Articles

Bortezomib Inhibit Acute Graft-Versus-Host Disease Via Shifting the Combination of T Cells Subpopulations

Jianyu Weng, Shaoze Lin, Peilong Lai, Meikun Lv, Xin Du, PhD, Wei Ling, Rong Guo, Chengwei Luo

Blood (2011) 118 (21): 4709.

https://doi.org/10.1182/blood.V118.21.4709.4709

Published: 2011

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Jianyu Weng, MD, Meikun Lü, MD, Xin Du, PhD, Lin Xu, PhD, Suxia Geng, MD, Rong Guo, PhD, Suijin Wu, MD, Wei Ling, PhD, Yuchun Wang

Blood (2009) 114 (22): 4499.

https://doi.org/10.1182/blood.V114.22.4499.4499

Published: 2009

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

Journal Articles

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Xin Du, PhD, Xuhui Yang, PhD, Wei Ling, PhD, Xia Tian, Maoxian Zou, Zhengguang Chen, Tao Wang, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Xiuming Zhang, Bruce T. Lahn, Andy Peng Xiang, PhD

Blood (2009) 114 (22): 4721.

https://doi.org/10.1182/blood.V114.22.4721.4721

Published: 2009

Journal Articles

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Jianyu Weng, MD, Xin Du, PhD/MD, Peng Xiang, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Wei Ling, MD

Blood (2008) 112 (11): 4364.

https://doi.org/10.1182/blood.V112.11.4364.4364

Published: 2008

Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2007) 110 (11): 4968.

https://doi.org/10.1182/blood.V110.11.4968.4968

Published: 2007

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

Journal Articles

A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation

George K. K. Lau, Albert K. W. Lie, Yok Lam Kwong, Cheuk Kwong Lee, Jinlin Hou, Yu Lung Lau, Wei Ling Lim, Raymond Liang

Blood (2000) 96 (2): 452–458.

https://doi.org/10.1182/blood.V96.2.452

Published: 2000

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

First-in-Class JAK/Rock Inhibitor Rovadicitinib in Myeloproliferative Neoplasms: A Single Arm, Multicenter, Open-Label, Phase I/Ib Study

Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center

Role of Donor-Derived CD19.CAR-T Cells in Treating Patients That Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Bortezomib Inhibit Acute Graft-Versus-Host Disease Via Shifting the Combination of T Cells Subpopulations

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

A case-controlled study on the use of HBsAg-positive donors for allogeneic hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only